Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients

• Main Authors: Sophie A. Kurk (Author), Petra H.M. Peeters (Author), Bram Dorresteijn (Author), Pim A. deJong (Author), Marion Jourdan (Author), Hugo J. Kuijf (Author), Cornelis J.A. Punt (Author), Miriam Koopman (Author), Anne M. May (Author)
• Format: Book
• Published: Wiley, 2018-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Observational studies suggest that loss of skeletal muscle mass (SMM) is associated with chemotherapy‐related toxicity, poor quality of life, and poor survival in metastatic colorectal cancer (mCRC) patients. Little is known about the evolution of SMM during palliative systemic t...